Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 3
1953 1
1954 1
1958 1
1961 1
1963 1
1969 1
1970 2
1971 1
1972 1
1973 1
1974 1
1976 1
1984 1
1988 1
1989 5
1990 3
1991 5
1992 2
1993 3
1994 2
1995 5
1996 2
1997 1
1998 1
1999 2
2000 4
2001 1
2002 4
2003 1
2004 2
2005 2
2006 6
2007 2
2008 5
2009 9
2010 4
2011 3
2012 9
2013 6
2014 10
2015 7
2016 4
2017 7
2018 5
2019 9
2020 10
2021 6
2022 8
2023 13
2024 12
2025 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

194 results

Results by year

Filters applied: . Clear all
Page 1
Continuation vs Discontinuation of Renin-Angiotensin System Inhibitors Before Major Noncardiac Surgery: The Stop-or-Not Randomized Clinical Trial.
Legrand M, Falcone J, Cholley B, Charbonneau H, Delaporte A, Lemoine A, Garot M, Joosten A, Meistelman C, Cheron-Leroy D, Rives JP, Pastene B, Dewitte A, Sigaut S, Danguy des Deserts M, Truc C, Boisson M, Lasocki S, Cuvillon P, Schiff U, Jaber S, Le Guen M, Caillard A, Bar S, Pereira de Souza Neto E, Colas V, Dimache F, Girardot T, Jozefowicz E, Viquesnel S, Berthier F, Vicaut E, Gayat E; Stop-or-Not Trial Group. Legrand M, et al. JAMA. 2024 Sep 24;332(12):970-978. doi: 10.1001/jama.2024.17123. JAMA. 2024. PMID: 39212270 Free PMC article. Clinical Trial.
Long-term efficacy and safety of luspatercept for the treatment of anaemia in patients with transfusion-dependent β-thalassaemia (BELIEVE): final results from a phase 3 randomised trial.
Cappellini MD, Viprakasit V, Georgiev P, Coates TD, Origa R, Khelif A, Liew HK, Tantiworawit A, Chew LP, Khalil A, Ho PJ, Kuo KHM, Holot N, Perin M, Giuseppi AC, Kuo WL, Lai Y, Medlin LF, Bueno LM, Kattamis A, Taher AT. Cappellini MD, et al. Among authors: perin m. Lancet Haematol. 2025 Mar;12(3):e180-e189. doi: 10.1016/S2352-3026(24)00376-4. Epub 2025 Feb 10. Lancet Haematol. 2025. PMID: 39947215 Clinical Trial.
Strategies for multivessel revascularization in patients with diabetes.
Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S 3rd, Bertrand M, Fuster V; FREEDOM Trial Investigators. Farkouh ME, et al. N Engl J Med. 2012 Dec 20;367(25):2375-84. doi: 10.1056/NEJMoa1211585. Epub 2012 Nov 4. N Engl J Med. 2012. PMID: 23121323 Free article. Clinical Trial.
EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening.
Cappelletto A, Alfì E, Volf N, Vu TVA, Bortolotti F, Ciucci G, Vodret S, Fantuz M, Perin M, Colliva A, Rozzi G, Rossi M, Ruozi G, Zentilin L, Vuerich R, Borin D, Lapasin R, Piazza S, Chiesa M, Lorizio D, Triboli L, Kumar S, Morello G, Tripodo C, Pinamonti M, Piperno GM, Benvenuti F, Rustighi A, Jo H, Piccolo S, Del Sal G, Carrer A, Giacca M, Zacchigna S. Cappelletto A, et al. Among authors: perin m. J Exp Clin Cancer Res. 2024 Jan 10;43(1):15. doi: 10.1186/s13046-023-02942-4. J Exp Clin Cancer Res. 2024. PMID: 38195652 Free PMC article.
Whole Exome Sequencing of Adult Patients With Evans Syndrome Reveals Pathogenic Variants Associated With Autoimmunity.
Crickx E, Fadlallah J, Cheminant M, Rosain J, Dion J, Malphettes M, Faucher B, Terriou L, Souchaud-Debouverie O, Comont T, Suarez F, Graveleau J, Hadjadj J, Moulinet T, Ronchetti AM, Ebbo M, Stolzenberg MC, Brunaud C, Ho-Nhat D, Masson C, Perin M, Richard-Colmant G, Willems L, Maigné G, Roux-Sauvat M, Gilardin L, Gousseff M, Bigot A, Froissart A, Moulis G, Puyade M, Dossier A, Boutboul D, Gobert D, Gourguechon C, Godeau B, Galicier L, Viallard JF, Audia S, Fieschi C, Hermine O, Michel M, Mahévas M, Rieux-Laucat F. Crickx E, et al. Among authors: perin m. Am J Hematol. 2025 Sep;100(9):1700-1704. doi: 10.1002/ajh.27767. Epub 2025 Jul 7. Am J Hematol. 2025. PMID: 40622000 No abstract available.
Light-emitting diode stimulates radiodermatitis recovery.
Camargo CP, Carvalho HA, Maluf FC, Sousa AADC, Perin POM, Perin MM, Morais-Besteiro J, Gemperli R. Camargo CP, et al. Among authors: perin mm. Acta Cir Bras. 2021 Feb 26;36(3):e360301. doi: 10.1590/ACB360301. eCollection 2021. Acta Cir Bras. 2021. PMID: 33656099 Free PMC article.
[Rabies].
Perin M. Perin M. Nouv Presse Med. 1972 Sep 23;1(33):2187-8. Nouv Presse Med. 1972. PMID: 4563094 French. No abstract available.
ZFHX4 truncating variant and orofacial clefting.
Sorrentino U, Fedrigo M, Calò AP, Perin M, Veronese P, Salviati L. Sorrentino U, et al. Among authors: perin m. Am J Med Genet A. 2024 Jan;194(1):115-116. doi: 10.1002/ajmg.a.63353. Epub 2023 Jul 11. Am J Med Genet A. 2024. PMID: 37434517 No abstract available.
Advance Care Planning in Neurodegenerative Disorders: A Scoping Review.
Giordano A, De Panfilis L, Perin M, Servidio L, Cascioli M, Grasso MG, Lugaresi A, Pucci E, Veronese S, Solari A. Giordano A, et al. Among authors: perin m. Int J Environ Res Public Health. 2022 Jan 12;19(2):803. doi: 10.3390/ijerph19020803. Int J Environ Res Public Health. 2022. PMID: 35055625 Free PMC article.
194 results